4. Conclusions
The study findings demonstrate that the low-cost CPAP-AirFlife™ CPAP device incorporating aerosol control headgear is not inferior to conventional equipment across various efficacy measures. These measures include hemoglobin oxygen saturation levels, exhaled PCOOne significant advantage of the CPAP-AirFlife™ device is its accessibility, particularly in resource-limited areas and lower-level hospitals where the cost and availability of treatments present significant challenges. The device’s affordability and local availability can significantly improve access to effective respiratory treatments, particularly in rural regions. This has profound implications for enhancing the quality of life and overall health of individuals with respiratory conditions requiring specialized care.Moreover, the portability and ease of use of the CPAP-AirFlife™ device make it a suitable option for patients needing CPAP therapy during transportation to specialized medical facilities. Its independence from external sources of medical air or electricity, along with its ergonomic and user-friendly design, allow for straightforward operation without requiring specialized personnel. Consequently, the CPAP-AirFlife™ device emerges as an efficient and convenient alternative for providing respiratory support in emergencies and during patient transfers to other medical centers.In summary, this study underscores the CPAP-AirFlife™ device as a viable and effective solution for addressing respiratory problems, particularly in resource-constrained areas. Its affordability, accessibility, and portability make it a valuable tool in improving respiratory care and overcoming the challenges faced by patients in underserved regions. By bringing effective respiratory treatments within reach, the CPAP-AirFlife™ device has the potential to improve the well-being of individuals in need significantly.